Reactivation of hepatitis in a bladder cancer patient receiving chemotherapy
スポンサーリンク
概要
- 論文の詳細を見る
Reactivation of hepatitis is a serious complication of chemotherapy in hepatitis B virus (HBV) carriers. There are many reports of this in lymphoma patients but few in urological cancer patients. A 59-year-old woman with bladder cancer who was an HBV carrier developed severe liver dysfunction after 2 cycles of chemotherapy. The diagnosis was reactivation of hepatitis. She improved with administration of lamivudine with a steroid and is currently well without disease. Care should be taken about the risk of reactivation when performing chemotherapy in HBV carriers and prophylaxis by lamivudine should be considered.
- Springer Netherlandsの論文
著者
-
Nonomura Katsuya
Department Of Urology Hokkaido University Graduate School Of Medicine
-
Shinohara Nobuo
Department Of Urology Hokkaido University Graduate School Of Medicine
-
Harabayashi Toru
Department Of Renal And Genitourinary Surgery Graduate School Of Medicine Hokkaido University
関連論文
- Laparoscopic removal of a retroperitoneal extralobar pulmonary sequestration in an adult
- Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy : A multi-institutional study
- Monozygotic Twins with Discordant Sexual Phenotypes due to Different Rations of Mosaicism of 47, X, idic(Y), idic(Y)/46, X, idic(Y)/45, X
- Gelsolin: a candidate for suppressor of human bladder cancer
- Management of Renal Angiomyolipomas Associated With Tuberous Sclerosis Complex
- Gelsolin gene silencing involving unusual hypersensitivities to dimethylsulfate and KMnO4 in vivo footprinting on its promoter region
- Peritoneal carcinomatosis in refractory seminoma
- Intravenous digital subtraction angiography and helical computed tomography in evaluation of living renal donors
- Pre-emptive renal transplantation in children
- Changes in renal blood flow in response to sympathomimetics in the rat transplanted and denervated kidney
- Kidney-Alone Transplantation in Diabetic Patients with End-Stage Renal Disease
- Parturition in Six Renal Allograft Recipients
- 両側の頸動脈小体腫瘍と両側の副腎褐色細胞腫を切除してから5年後に精索に異所性褐色細胞腫が発生した1例
- Reappraisal of Tc-99m DMSA scintigraphy for follow up in children with vesicoureteral reflux
- The Estimated Prevalence of Hypospadias in Hokkaido, Japan
- Qualitative and quantitative evaluation of renal parenchymal damage by ^Tc-DMSA planar and SPECT scintigraphy
- MANAGEMENT AND OUTCOME OF ANTENATALLY DIAGNOSED HYDRONEPHROSIS
- IN VIVO EFFECT OF A SELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST, BQ-123, ON RENAL FUNCTION IN CYCLOSPORIN A-TREATED RATS
- Alternative approach in the treatment of adrenal metastasis with a real-time tracking radiotherapy in patients with hormone refractory prostate cancer
- Reactivation of hepatitis in a bladder cancer patient receiving chemotherapy
- Medical management of recurrent aggressive angiomyxoma with gonadotropin-releasing hormone agonist
- Laparoscopic ureteroureterostomy for retrocaval ureter
- Kidney Transplantation in Patients with Neurovesical Dysfunction
- CONTINENCE MECHANISM OF THE ORTHOTOPIC NEOBLADDER: URODYNAMIC ANALYSIS OF ILEOCOLIC NEOBLADDER AND EXTERNAL URETHRAL SPHINCTER FUNCTIONS
- Infiltration of Epstein-Barr virus-harboring lymphocytes occurs in a large subset of bladder cancers
- Complications of bacillus Calmette-Guerin therapy in superficial urothelial cancer : clinical analysis and implications
- Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice
- Advanced renal pelvic carcinoma associated with dermatomyositis
- Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer
- The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma
- Treatment of Metastatic Nonseminomatous Germ Cell Tumors of the Testis: Significance of the International Consensus Prognostic Classification as a Prognostic Factor-Based Staging System
- Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.
- Multiple primary malignancies in Japanese patients with renal cell carcinoma
- Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas : identification of a novel nonsense mutation (Q168X) in the SDHB gene